Home Blog Page 1435

Frost & Sullivan: Mercanis Receives the 2025 European Agentic AI Product Leadership Recognition for its Excellence in Intelligent Procurement Transformation

Frost & Sullivan recognizes Mercanis for product innovation, customer-centricity, and AI leadership in redefining digital procurement across Europe.

SAN ANTONIO, Jan. 26, 2026 /PRNewswire/ — Frost & Sullivan is pleased to announce that Mercanis has been honored with the 2025 European Product Leadership Recognition in the procurement sector for its outstanding achievements in product innovation, automation, and customer-centric digital transformation. This recognition highlights Mercanis’s consistent leadership in driving efficiency, agility, and resilience while building customer trust through strong data governance and an AI-enhanced procurement environment.

Guided by a long-term growth strategy focused on digital procurement transformation, an AI-enhanced environment, and an orchestration-first approach, Mercanis has shown its ability to adapt and lead in a rapidly evolving landscape. The company’s strategic agility and sustained investment in automation, data-driven intelligence, and resilient procurement architectures have enabled it to scale effectively across European markets, including Germany, Switzerland, and the United Kingdom.

Innovation is central to Mercanis’s approach. Mercanis combines a unified procurement backbone with an intelligent AI layer, bringing both the core platform and agentic intelligence into one connected system. Its AI-driven architecture reimagines procurement through intelligent automation, advanced analytics, and a highly user-centric design. By eliminating manual work, unifying fragmented data into a single source of truth, and delivering full visibility across categories and geographies, Mercanis enables faster, more informed decision-making. Mercanis empowers procurement teams to enhance efficiency, compliance, and collaboration across the entire S2C lifecycle. Building on agentic AI, the company continues to introduce new agents and capabilities that operate directly within this backbone, strengthening enterprise resilience and significantly accelerating buyer productivity.

“Frost & Sullivan commends Mercanis for its relentless innovation in redefining what modern procurement software can achieve. The company demonstrates foresight in anticipating industry trends and agility in turning market shifts into a competitive advantage. These strengths position it as a first mover in shaping the next generation of intelligent, connected, and human-centered procurement solutions,” said Heena Juneja, industry principal at Frost & Sullivan. “For the first time, technology is truly ready to address the growing geopolitical, operational, and structural complexity of global procurement. With Mercanis, we are moving procurement from fragmented tools and manual coordination to an AI-orchestrated operating model – where specialized AI agents connect data, guide execution, and give teams back control, speed, and strategic focus,” said Fabian Heinrich, CEO & Co-Founder of Mercanis. 

Mercanis’s unwavering commitment to customer experience further strengthens its leadership position. By aligning product innovation with real-world procurement challenges and embedding customer-centricity into its platform design, the company consistently enhances user adoption, transparency, and trust. Strong data governance and secure architectures ensure reliability while supporting scalable, compliant procurement operations for diverse industries, including manufacturing, pharmaceuticals, energy, and utilities.

Frost & Sullivan commends Mercanis for setting a high standard in product leadership, innovation, and market responsiveness. The company’s vision, continuous innovation pipeline, and focus on intelligent orchestration are shaping the future of procurement and enabling enterprises to transform procurement into a strategic, data-driven function.

Each year, Frost & Sullivan presents the Product Leadership Recognition to a company that demonstrates outstanding product strategy and execution, resulting in measurable improvements in efficiency, customer satisfaction, and competitive positioning. It recognizes forward-thinking organizations that are reshaping their industries through innovation and growth excellence.

Frost & Sullivan Best Practices Recognition

Frost & Sullivan’s Best Practices Recognitions honor companies across regional and global markets that exhibit exceptional achievement and consistent excellence in areas such as leadership, technological innovation, customer experience, and strategic product development. Each recognition is the result of a rigorous analytical process in which Frost & Sullivan industry experts benchmark performance through comprehensive interviews, deep-dive analysis, and extensive secondary research. The goal is to identify true best-in-class organizations that are driving transformative growth and setting new industry standards.
Contact us: Start the discussion.

Contact

Camila Tinajero
E: camila.tinajero@frost.com 

About Mercanis

Mercanis is the AI platform for the agentic procurement era. Founded in 2020, Mercanis helps organizations transform fragmented procurement environments into one connected, intelligent operating model.

Whether deployed as a full procurement platform or as an agentic AI layer on top of existing systems, Mercanis unifies your procurement function and uses 55 specialized AI agents to orchestrate the entire procurement lifecycle.

Today, Mercanis supports more than 50 customers across multiple industries and operates with a team of over 80 employees across Europe and the United States, with three technology hubs across two continents.

HOTLIST 2025 HONOURS HO CHI MINH CITY, HUE AND QUANG NINH AS IMPRESSIVE DESTINATIONS OF THE YEAR

HANOI, Vietnam, Jan. 26, 2026 /PRNewswire/ — Following a series of professional and networking activities under the HOTLIST Travellive Editor’s Pick 2025 (HOTLIST 2025) project, The Honor Ceremony celebrated outstanding brands, destinations and individuals for their significant contributions to the tourism industry, with special recognition given to three impressive destinations of the year: Ho Chi Minh City, Hue and Quang Ninh. The project is organised by Travellive Media Group with the aim of building a platform that connects stakeholders and recognises positive contributions to the development of the industry.

Building on the success of previous editions, HOTLIST 2025 adopted the theme “The Journey from Seed to Harvest”, a familiar metaphor in Vietnamese culture that reflects the growth journey of brands, destinations and individuals in the tourism and hospitality sector. From initial ideas and long-term investment to tangible achievements, the project highlights values that are nurtured and strengthened over time.

Beyond announcing the honourees, HOTLIST 2025 featured a series of multi-dimensional activities, most notably two professional conferences, The Insiders Forum held in Hanoi and Ho Chi Minh City. The forums attracted more than 700 guests, including business leaders, experts, policymakers and representatives from tourism and hospitality brands, airlines, destinations and media organisations. They were regarded as one of the year’s notable industry forums, providing a platform for dialogue, knowledge sharing and practical insights.

As the core activity of the project, The Honor Ceremony served not only as an occasion to recognise the brands and individuals listed in HOTLIST 2025, but also as a meaningful networking space for the tourism community. The event welcomed over 250 guests, including representatives from government agencies, domestic and international tourism promotion organisations, and the wider tourism and hospitality business community.

At The Honor Ceremony – HOTLIST 2025, three impressive destinations of 2025 were announced: Ho Chi Minh City, Hue and Quang Ninh. These destinations were recognised for their strong performance in tourism promotion and marketing, as well as their efforts in advancing sustainable tourism development. The honour acknowledges the notable achievements, contributions and long-term commitment of the local authorities to the overall growth of Vietnam’s tourism sector.

Over the past year, Ho Chi Minh City welcomed 45 million domestic visitors and 8.5 million international arrivals, reinforcing its important role in the broader development of the industry. The city expanded its signature tourism routes, hosted large-scale events and meaningful commemorative programmes, contributing significantly to total tourism revenue of over VND 278 trillion. In addition, effective communication campaigns and a clear focus on interregional, medical, eco and sustainable tourism continued to strengthen Ho Chi Minh City’s position as a national hub connecting and spreading tourism value across the country.

With strong results achieved, Quang Ninh and Hue are recognised as two outstanding destinations within Vietnam’s tourism landscape. Quang Ninh stood out with robust visitor growth and enhanced its destination value when the Yen Tu – Vinh Nghiem – Con Son, Kiep Bac complex was recognised by UNESCO as a World Cultural Heritage Site, promoting the image of a destination that harmonises heritage, nature and sustainable development. Meanwhile, Hue marked a clear transformation as host of the National Tourism Year 2025, accelerating cultural and festival activities and advancing its green and sustainable tourism orientation, thereby improving visitor experience and overall destination appeal.

In addition, HOTLIST 2025 recognised 42 outstanding brands and 12 individuals across various sectors of the tourism industry, from accommodation, travel and aviation to experiences and services. The recognition reflects their commitment to innovation, operational excellence, sustainable development strategies and positive contributions to enhancing the image, competitiveness and appeal of Vietnam’s tourism sector.

With a strong focus on celebrating heritage and national identity as a key pillar of sustainable tourism development, The Honor Ceremony featured carefully curated artistic performances that highlighted Vietnamese cultural values. Performances such as “Tinh hoa Hạt Ngọc”, inspired by this year’s theme, “Vó ngựa trên mây” performed by Meritorious Artist Duong Thuy Anh, along with contemporary interpretations of traditional music, created an emotional atmosphere where local cultural values were presented within the context of modern tourism development.

The success of The Honor Ceremony was made possible with the support of partners and sponsors. Ford Vietnam joined as the Diamond Sponsor, JW Marriott Hotel & Suites Saigon served as the Venue Sponsor, while Lady Trieu, BM Wine participated as Beverage experience partners. Eventista supported the project as the Strategic technology partner and official voting platform, and Jourdeness joined as The gift partner. The The Insiders Forum conferences were co-organised in partnership with The Brand Promise.

HOTLIST 2025 attracted strong attention from both domestic and international media, with PR Newswire and Hotelier Vietnam joining as Media Partners, helping to amplify the project’s messages and values across local and global media platforms.

Held on the evening of January 19 in Ho Chi Minh City, The Honor Ceremony marked the conclusion of HOTLIST 2025 under the theme “The Journey from Seed to Harvest”. Prior to the gala, the project featured a range of activities, including the announcement of the HOTLIST, a public voting phase and professional forums in Hanoi and Ho Chi Minh City. As a reputable annual initiative organised by Travellive Media Group, the project attracted the participation of more than 1,000 senior executives and received widespread attention from the tourism and hospitality community both in Vietnam and internationally.

Through HOTLIST 2025, Travellive continues to pursue its long-term content strategy, acting as a bridge between businesses, experts and the wider community. As the tourism industry continues to evolve, HOTLIST is expected to remain a platform that recognises enduring values, shares positive development stories and contributes to the sustainable growth of Vietnam’s tourism sector in the years ahead.

 MS. NGUYEN THI LINH NGA
PR Executive Travellive Media Group
Email: pr@vntravellive.com

 

Origin Agritech to Hold Business Update & Fiscal Year 2025 Earnings Conference Call on Monday, February 2 at 8 a.m. ET

BEIJING, Jan. 26, 2026 /PRNewswire/ — Origin Agritech Ltd. (NASDAQ: SEED) (the “Company” or “Origin”), a leading Chinese agricultural technology company, will announce its financial results for fiscal year 2025 on Friday, January 30. Origin will host a conference call on Monday, February 2, at 8 a.m. ET with the investment community to discuss the Company’s financial results and provide a business update.

The Company will also file its annual report on Form 20-F on Friday, January 30.

CONFERENCE CALL & AUDIO WEBCAST

The conference call will be led by Mr. Weibin Yan, Chief Executive Officer, and Mr. Patrick Cheng, Chief Financial Officer, who will be available to answer questions.

Investors may submit written questions by January 29 via email to: matthew@strategic-ir.com.   

To access the call by phone, please call 1-800-245-3047 (United States) or 1-203-518-9765 (International) using the conference ID: ORIGIN.

To avoid delays, we encourage participants to dial into the conference call 15 minutes before the scheduled start time. The webcast can be accessed at the following link: https://viavid.webcasts.com/starthere.jsp?ei=1750839&tp_key=695fe18547.

A webcast replay will be available for two weeks.

About Origin Agritech Limited

Origin Agritech Limited, founded in 1997 and headquartered at the Origin R&D Center in Songzhuang, Tongzhou, Beijing, is a leading Chinese agricultural technology company. In crop seed biotechnologies, Origin Agritech’s phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China’s Ministry of Agriculture. Over the years, Origin has established a robust biotechnology seed pipeline, including products with glyphosate tolerance and Bt (pest resistance) traits. For further information, please visit the Company’s website at www.originagritech.com. The Company also maintains an X account to update investors on Company and industry developments, available at https://x.com/origin_agritech.

Forward-Looking Statements

This communication contains “forward-looking statements” as defined in the federal securities laws, including Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements address expected future business and financial performance and financial condition and contain words like “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “will,” “would,” “target,” and similar expressions and variations. Forward-looking statements address matters that are uncertain. Forward-looking statements are not guarantees of future performance and are based on assumptions and expectations that may not be realized. They are based on management’s current expectations, assumptions, estimates, and projections about the Company and the industry in which the Company operates but involve a number of risks and uncertainties, many of which are beyond the Company’s control. Some of the important factors that could cause the Company’s actual results to differ materially from those discussed in forward-looking statements are: failure to develop and market new products and optimally manage product life cycles; ability to respond to market acceptance, rules, regulations and policies affecting our products; failure to appropriately manage process safety and product stewardship issues; changes in laws and regulations or political conditions; global economic and capital markets conditions, such as inflation, interest and currency exchange rates; business or supply disruptions; natural disasters and weather events and patterns; ability to protect and enforce the Company’s intellectual property rights; and separation of underperforming or non-strategic assets or businesses. The Company undertakes no duty or obligation to publicly revise or update any forward-looking statements as a result of future developments, new information, or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure that such expectations will be correct. Actual results may differ materially from the anticipated results. You are urged to consider these factors carefully in evaluating the forward-looking statements contained herein. You are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements.

For more information, please contact:
Origin Agritech Limited Contact:
Kate Lang (Mandarin/English)
Director of Investor Relations
Phone: +86 186-1839-3368
Email: bing.lang@originseed.com.cn 

Investor Relations Contact:
Matthew Abenante, IRC
President
Strategic Investor Relations, LLC
Tel: 347-947-2093
Email: matthew@strategic-ir.com

Farmmi, Inc. Establishes New U.S. Subsidiary to Focus on Digital Marketing Business

LISHUI, China, Jan. 26, 2026 /PRNewswire/ — Farmmi, Inc. (NASDAQ: FAMI) (“Farmmi” or the “Company”), today announced the establishment of a wholly-owned U.S. subsidiary, Bluesage Marketing Inc, which will conduct marketing business. This marks the Company’s latest strategic development and the first step in its entry into the AI-driven digital marketing industry.

Strategic Significance: The Leap from “Product Supply” to “Commercial Enablement”

The Company considers an entry into the digital marketing industry represents a milestone for Farmmi. It will extend the Company’s business landscape from traditional supply chain services to the top of the value chain: brand building and customer acquisition.

Forging a New Growth Engine: Upon the integration of advanced AI and Big Data analytics technologies in its operations, Bluesage will be positioned to provide cross-border marketing solutions for its clients and contribute to the Company’s overall profitability through digital services.

Building a Complete Ecosystem: The new business aims to connect “backend logistics fulfillment” with “frontend customer acquisition,” and enhance the platform’s customer stickiness and competitiveness with respect to customer acquisition.

Ms. Yefang Zhang, CEO of Farmmi, Inc., commented:

“The establishment of Bluesage Marketing Inc. marks Farmmi’s U.S. operational expansion from downstream logistics services to a more complete supply chain system featuring ‘Smart Logistics + Smart Marketing.’ Through this strategic extension, we are hopeful that Farmmi will be able to provide global clients with end-to-end full-chain empowerment ranging from logistics to sales.”

About Farmmi, Inc.

Founded in 1998, Farmmi, Inc. (Nasdaq: FAMI) is an agricultural products supplier, distributor and logistics service provider, with a focus on edible mushrooms (including shiitake and wood ear mushrooms) and other agricultural products. The Company distributes high-quality agricultural goods to the global markets primarily through its established distribution channels. For more information, please visit the Farmmi official website.

Forward-Looking Statements

This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities. Such offers may only be made in accordance with the Securities Act of 1933, as amended, and applicable state securities laws.

Certain statements in this press release regarding the Company’s future growth prospects are forward-looking statements made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks and uncertainties that may cause actual results to differ materially from those expressed or implied in such statements. These risks and uncertainties include, but are not limited to: our ability to secure financing on favorable terms, customer order fulfillment, earnings volatility, exchange rate fluctuations, our ability to manage growth, the ability to generate revenue from business expansion and acquisitions, our ability to attract and retain qualified professionals, customer concentration, segment concentration, and other factors affecting the general economic conditions of the industry. Further information regarding these and other risks is included in the Company’s filings with the U.S. Securities and Exchange Commission (SEC), which are available at www.sec.gov. Farmmi may also make additional forward-looking statements from time to time in written or oral form, including in filings with the SEC and in reports to shareholders. Please note that all forward-looking statements are based on current assumptions believed to be reasonable as of the date of this press release. The Company undertakes no obligation to update or revise any forward-looking statements, except as required by law.

For more information, please contact: 

Farmmi, Inc.
Investor Relations
Tel: +86-0578-82612876
ir@farmmi.com

Divamics Showcases Lead Autoimmune Program DVI-001 and Unveils New Metabolic Program DVI-004 at JPM Week 2026

SAN FRANCISCO, Jan. 26, 2026 /PRNewswire/ — Divamics (DIVAMICS), an AI-driven biotechnology company specializing in high-precision molecular discovery, highlighted the significant advancement of its internal pipeline during the Biotech Showcase™ at JPM Week 2026. The company provided updated milestones for its lead autoimmune program, DVI-001, and announced the first disclosure of DVI-004, a promising new metabolic disease program generated by its proprietary AI platform. The presentation centered on Divamics’ ability to bridge the gap between AI-driven prediction and clinical-ready assets.

Dr. John Zheng, Founder and CEO of Divamics, presents data from the partner program BGM1812 during Biotech Showcase™ at JPM Week 2026
Dr. John Zheng, Founder and CEO of Divamics, presents data from the partner program BGM1812 during Biotech Showcase™ at JPM Week 2026

A Foundation in Molecular Excellence

Founded in 2021, Divamics is led by a founding team with deep roots in the global computational chemistry community. CEO Dr. John Zheng and Dr. Hao Liu both earned their Ph.D.s from the University of Florida, training within the prestigious AMBER molecular dynamics ecosystem.

During his tenure in the U.S., Dr. Zheng pioneered the MovableType free energy algorithm, which secured a second-place global ranking in the SAMPL6 blind drug design challenge and earned commendation from Nobel Laureate Roald Hoffmann. The technology’s industrial viability was further validated through its commercial integration by QuantumBio. This academic rigor is complemented by Dr. Liu’s extensive experience at Genentech, where she specialized in large-scale data architecture—a critical pillar for Divamics’ AI-driven insights.

The company’s scientific strategy is guided by Dr. Kenneth M. Merz Jr., Chief Scientific Advisor and a world-renowned authority in computational chemistry, ensuring that Divamics remains at the forefront of molecular simulation technology.

Market Validation and Strategic Global Footprint

Divamics‘ technological prowess is backed by strong commercial momentum. At the Showcase, the company highlighted its ongoing collaboration with BrightGene, which recently resulted in peer-reviewed research published in the Journal of Medicinal Chemistry (2025). The market’s interest in Divamics’ platform was further evidenced by more than 50 high-level partnering meetings with global biopharma stakeholders during JPM Week.

“JPM Week is the ideal stage to share our progress with the global life sciences community,” said Dr. John Zheng, Founder and CEO of Divamics. “By combining our U.S.-trained scientific expertise with China’s robust and agile biotech infrastructure, we offer global partners a unique value proposition: high-precision molecular discovery delivered with exceptional capital efficiency and executional speed.”

Divamics operates with a strategic global footprint, including its headquarters in Suzhou, operational teams in Shanghai and Beijing, and a Singapore hub dedicated to fostering international R&D collaborations.

About Divamics

Divamics is an AI-driven biotech company dedicated to bringing molecular precision to early-stage R&D. By integrating physics-based molecular dynamics with machine learning, Divamics accelerates the transition from hit identification to preclinical candidate selection. The company offers both collaborative R&D services and a growing internal pipeline of partner-ready assets.

Media Contact: Divamics, Marketing Department, marketing@divamics.com 

Origin Agritech to Hold Business Update & Fiscal Year 2025 Earnings Conference Call on Monday, February 2 at 8 a.m. ET

BEIJING, Jan. 26, 2026 /PRNewswire/ — Origin Agritech Ltd. (NASDAQ: SEED) (the “Company” or “Origin”), a leading Chinese agricultural technology company, will announce its financial results for fiscal year 2025 on Friday, January 30. Origin will host a conference call on Monday, February 2, at 8 a.m. ET with the investment community to discuss the Company’s financial results and provide a business update.

The Company will also file its annual report on Form 20-F on Friday, January 30.

CONFERENCE CALL & AUDIO WEBCAST

The conference call will be led by Mr. Weibin Yan, Chief Executive Officer, and Mr. Patrick Cheng, Chief Financial Officer, who will be available to answer questions.

Investors may submit written questions by January 29 via email to: matthew@strategic-ir.com.   

To access the call by phone, please call 1-800-245-3047 (United States) or 1-203-518-9765 (International) using the conference ID: ORIGIN.

To avoid delays, we encourage participants to dial into the conference call 15 minutes before the scheduled start time. The webcast can be accessed at the following link: https://viavid.webcasts.com/starthere.jsp?ei=1750839&tp_key=695fe18547.

A webcast replay will be available for two weeks.

About Origin Agritech Limited

Origin Agritech Limited, founded in 1997 and headquartered at the Origin R&D Center in Songzhuang, Tongzhou, Beijing, is a leading Chinese agricultural technology company. In crop seed biotechnologies, Origin Agritech’s phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China’s Ministry of Agriculture. Over the years, Origin has established a robust biotechnology seed pipeline, including products with glyphosate tolerance and Bt (pest resistance) traits. For further information, please visit the Company’s website at www.originagritech.com. The Company also maintains an X account to update investors on Company and industry developments, available at https://x.com/origin_agritech.

Forward-Looking Statements

This communication contains “forward-looking statements” as defined in the federal securities laws, including Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements address expected future business and financial performance and financial condition and contain words like “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “will,” “would,” “target,” and similar expressions and variations. Forward-looking statements address matters that are uncertain. Forward-looking statements are not guarantees of future performance and are based on assumptions and expectations that may not be realized. They are based on management’s current expectations, assumptions, estimates, and projections about the Company and the industry in which the Company operates but involve a number of risks and uncertainties, many of which are beyond the Company’s control. Some of the important factors that could cause the Company’s actual results to differ materially from those discussed in forward-looking statements are: failure to develop and market new products and optimally manage product life cycles; ability to respond to market acceptance, rules, regulations and policies affecting our products; failure to appropriately manage process safety and product stewardship issues; changes in laws and regulations or political conditions; global economic and capital markets conditions, such as inflation, interest and currency exchange rates; business or supply disruptions; natural disasters and weather events and patterns; ability to protect and enforce the Company’s intellectual property rights; and separation of underperforming or non-strategic assets or businesses. The Company undertakes no duty or obligation to publicly revise or update any forward-looking statements as a result of future developments, new information, or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure that such expectations will be correct. Actual results may differ materially from the anticipated results. You are urged to consider these factors carefully in evaluating the forward-looking statements contained herein. You are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements.

For more information, please contact:
Origin Agritech Limited Contact:
Kate Lang (Mandarin/English)
Director of Investor Relations
Phone: +86 186-1839-3368
Email: bing.lang@originseed.com.cn 

Investor Relations Contact:
Matthew Abenante, IRC
President
Strategic Investor Relations, LLC
Tel: 347-947-2093
Email: matthew@strategic-ir.com

Farmmi, Inc. Establishes New U.S. Subsidiary to Focus on Digital Marketing Business

LISHUI, China, Jan. 26, 2026 /PRNewswire/ — Farmmi, Inc. (NASDAQ: FAMI) (“Farmmi” or the “Company”), today announced the establishment of a wholly-owned U.S. subsidiary, Bluesage Marketing Inc, which will conduct marketing business. This marks the Company’s latest strategic development and the first step in its entry into the AI-driven digital marketing industry.

Strategic Significance: The Leap from “Product Supply” to “Commercial Enablement”

The Company considers an entry into the digital marketing industry represents a milestone for Farmmi. It will extend the Company’s business landscape from traditional supply chain services to the top of the value chain: brand building and customer acquisition.

Forging a New Growth Engine: Upon the integration of advanced AI and Big Data analytics technologies in its operations, Bluesage will be positioned to provide cross-border marketing solutions for its clients and contribute to the Company’s overall profitability through digital services.

Building a Complete Ecosystem: The new business aims to connect “backend logistics fulfillment” with “frontend customer acquisition,” and enhance the platform’s customer stickiness and competitiveness with respect to customer acquisition.

Ms. Yefang Zhang, CEO of Farmmi, Inc., commented:

“The establishment of Bluesage Marketing Inc. marks Farmmi’s U.S. operational expansion from downstream logistics services to a more complete supply chain system featuring ‘Smart Logistics + Smart Marketing.’ Through this strategic extension, we are hopeful that Farmmi will be able to provide global clients with end-to-end full-chain empowerment ranging from logistics to sales.”

About Farmmi, Inc.

Founded in 1998, Farmmi, Inc. (Nasdaq: FAMI) is an agricultural products supplier, distributor and logistics service provider, with a focus on edible mushrooms (including shiitake and wood ear mushrooms) and other agricultural products. The Company distributes high-quality agricultural goods to the global markets primarily through its established distribution channels. For more information, please visit the Farmmi official website.

Forward-Looking Statements

This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities. Such offers may only be made in accordance with the Securities Act of 1933, as amended, and applicable state securities laws.

Certain statements in this press release regarding the Company’s future growth prospects are forward-looking statements made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks and uncertainties that may cause actual results to differ materially from those expressed or implied in such statements. These risks and uncertainties include, but are not limited to: our ability to secure financing on favorable terms, customer order fulfillment, earnings volatility, exchange rate fluctuations, our ability to manage growth, the ability to generate revenue from business expansion and acquisitions, our ability to attract and retain qualified professionals, customer concentration, segment concentration, and other factors affecting the general economic conditions of the industry. Further information regarding these and other risks is included in the Company’s filings with the U.S. Securities and Exchange Commission (SEC), which are available at www.sec.gov. Farmmi may also make additional forward-looking statements from time to time in written or oral form, including in filings with the SEC and in reports to shareholders. Please note that all forward-looking statements are based on current assumptions believed to be reasonable as of the date of this press release. The Company undertakes no obligation to update or revise any forward-looking statements, except as required by law.

For more information, please contact: 

Farmmi, Inc.
Investor Relations
Tel: +86-0578-82612876
ir@farmmi.com

Divamics Showcases Lead Autoimmune Program DVI-001 and Unveils New Metabolic Program DVI-004 at JPM Week 2026

SAN FRANCISCO, Jan. 26, 2026 /PRNewswire/ — Divamics (DIVAMICS), an AI-driven biotechnology company specializing in high-precision molecular discovery, highlighted the significant advancement of its internal pipeline during the Biotech Showcase™ at JPM Week 2026. The company provided updated milestones for its lead autoimmune program, DVI-001, and announced the first disclosure of DVI-004, a promising new metabolic disease program generated by its proprietary AI platform. The presentation centered on Divamics’ ability to bridge the gap between AI-driven prediction and clinical-ready assets.

Dr. John Zheng, Founder and CEO of Divamics, presents data from the partner program BGM1812 during Biotech Showcase™ at JPM Week 2026
Dr. John Zheng, Founder and CEO of Divamics, presents data from the partner program BGM1812 during Biotech Showcase™ at JPM Week 2026

A Foundation in Molecular Excellence

Founded in 2021, Divamics is led by a founding team with deep roots in the global computational chemistry community. CEO Dr. John Zheng and Dr. Hao Liu both earned their Ph.D.s from the University of Florida, training within the prestigious AMBER molecular dynamics ecosystem.

During his tenure in the U.S., Dr. Zheng pioneered the MovableType free energy algorithm, which secured a second-place global ranking in the SAMPL6 blind drug design challenge and earned commendation from Nobel Laureate Roald Hoffmann. The technology’s industrial viability was further validated through its commercial integration by QuantumBio. This academic rigor is complemented by Dr. Liu’s extensive experience at Genentech, where she specialized in large-scale data architecture—a critical pillar for Divamics’ AI-driven insights.

The company’s scientific strategy is guided by Dr. Kenneth M. Merz Jr., Chief Scientific Advisor and a world-renowned authority in computational chemistry, ensuring that Divamics remains at the forefront of molecular simulation technology.

Market Validation and Strategic Global Footprint

Divamics‘ technological prowess is backed by strong commercial momentum. At the Showcase, the company highlighted its ongoing collaboration with BrightGene, which recently resulted in peer-reviewed research published in the Journal of Medicinal Chemistry (2025). The market’s interest in Divamics’ platform was further evidenced by more than 50 high-level partnering meetings with global biopharma stakeholders during JPM Week.

“JPM Week is the ideal stage to share our progress with the global life sciences community,” said Dr. John Zheng, Founder and CEO of Divamics. “By combining our U.S.-trained scientific expertise with China’s robust and agile biotech infrastructure, we offer global partners a unique value proposition: high-precision molecular discovery delivered with exceptional capital efficiency and executional speed.”

Divamics operates with a strategic global footprint, including its headquarters in Suzhou, operational teams in Shanghai and Beijing, and a Singapore hub dedicated to fostering international R&D collaborations.

About Divamics

Divamics is an AI-driven biotech company dedicated to bringing molecular precision to early-stage R&D. By integrating physics-based molecular dynamics with machine learning, Divamics accelerates the transition from hit identification to preclinical candidate selection. The company offers both collaborative R&D services and a growing internal pipeline of partner-ready assets.

Media Contact: Divamics, Marketing Department, marketing@divamics.com